LTRN CIK: 1763950

Lantern Pharma Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.6
FY22:
−12.8
FY23:
−14.3
FY24:
−17.8
FY25:
−15.7
Change from FY21 to FY25
millions USD
FY21:
−19.5
FY22:
0.18
FY23:
−0.93
FY24:
3.37
FY25:
11.1
Change from FY21 to FY25
millions USD
FY21:
63.4
FY22:
−2.18
FY23:
−0.50
FY24:
0.07
FY25:
1.50
millions USD
FY21:
33.3
FY22:
−14.8
FY23:
−15.8
FY24:
−14.4
FY25:
−3.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.6
FY22:
−12.8
FY23:
−14.4
FY24:
−17.8
FY25:
−15.7

All amounts in millions USD Data source:SEC EDGAR